Deerfield Management Company, L.P. (Series C) Neuronetics, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$4.04 Billion
Q4 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$10.15 - $17.25 $9.33 Million - $15.9 Million	-919,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$4.95 - $11.45 $3.25 Million - $7.51 Million	-656,000 Reduced 41.65%	919,000 $10.2 Million
Q3 2020 Nov 16, 2020	SELL	$1.82 - $5.87 $215,336 - $694,520	-118,317 Reduced 6.99%	1,575,000 $7.66 Million
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.61 $166,826 - $308,807	118,317 Added 7.51%	1,693,317 $3.27 Million
Q1 2020 May 15, 2020	BUY	$1.28 - $4.5 $640,000 - $2.25 Million	500,000 Added 46.51%	1,575,000 $2.98 Million
Q4 2019 Feb 14, 2020	BUY	$4.03 - $9.22 $2.96 Million - $6.78 Million	735,488 Added 216.63%	1,075,000 $4.83 Million
Q3 2019 Nov 14, 2019	BUY	$8.31 - $13.03 $1.5 Million - $2.35 Million	180,512 Added 113.53%	339,512 $2.82 Million
Q4 2018 Feb 14, 2019	BUY	$16.0 - $31.84 $2.54 Million - $5.06 Million	159,000 New	159,000 $3.08 Million
Q3 2018 Nov 14, 2018	SELL	$24.32 - $37.54 $3.04 Million - $4.69 Million	-125,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$26.61 - $27.78 $3.33 Million - $3.47 Million	125,000 New	125,000 $3.33 Million

Others Institutions Holding STIM

# of Institutions

Shares Held

10M

Call Options Held

24.1K

Put Options Held

200

Kent Lake Capital LLC Mill Valley, CA

1.74M
Shares

$7.39 Million
1.44% of portfolio
Masters Capital Management LLC Atlanta, GA

1.5M
Shares

$6.38 Million
0.08% of portfolio
Balyasny Asset Management LLC Chicago, IL

1.48M
Shares

$6.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.28M
Shares

$5.45 Million
0.0% of portfolio
Four World Capital Management LLC New York, NY

858K
Shares

$3.65 Million
0.69% of portfolio

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $115M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account